Feed 6709.TWO
67
Advagene Biopharma Co., Ltd.
6709.TWO · TWO
$24.50 +2.08% (+$0.50)
1M +0.00%
Market Cap $1.68B
P/E Ratio -
Div. Yield -
ROE 29.80%
Bulios Fair Price
$12.68
48.2% downside
Current Price
$24.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6709.TWO is currently overvalued relative to its market price. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 11.00x
EV/EBITDA N/A
P/S N/A
Growth
50 /100
Stable Book val. growth 4.94%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 29.80%
ROA 41.01%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 13.69x
Int. coverage -405.25x
Debt/Equity 0.04x
Stability
80 /100
Stable EPS volatility 10.79%
Profitable years 0
Beta 0.66x
Ask StockBot about 6709.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yu-Shen Hsu
Employees
16
Headquarters
Taipei